MyShare
US Market news
headline news | recent news | latest news | market news | recent topics | stock topics
Global news - chevrons indicate local prediction, arrows show global predictions, circles show importance
| INFY US | Infosys: Strong large deal TCV of $4.5 billion in Q4 and record $17.7 billion in FY24 create robust foundation for growth FY25 guidance - revenue growth of 1%-3% and operating margin of 20%-22% BENGALURU, India, April 18, 2024 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered $18.6 billion in FY24 revenues with a growth... - prnewswire:443 | 22m ago link | |
| INFY US | Infosys Stock Falls After Q4 Earnings - What's Going On? Infosys Ltd (NYSE: INFY) reported fourth-quarter revenue growth of 0.2% year-on-year to $4.56 billion, beating the consensus of $4.52 billion. Revenues in constant currency (CC) terms remained flat year over year and declined by 2.2% quarter over quarter . EPS of $0.23 beat the Street analyst estimate of $0.17, up from $0.18 a year ago. TCV's significant deal win was $4.5 billion. The operating margin declined by 90 bps to 20.1%. Infosys held $1.8 billion in cash and equivalents as of March 31, 2024. It ... Full story available on Benzinga.com - benzinga | 35m ago link | |
| NFLX US | Netflix Stock Is In The Spotlight Thursday: What's Going On? Netflix Inc (NASDAQ: NFLX ) shares are in the spotlight Thursday ahead of earnings. Here’s what you need to know . What To Know: Netflix is set to report first-quarter financial results after the bell on Thursday. Analysts expect the streaming giant to report earnings of $4.52 per share and revenue of $9.275 billion, according to estimates from Benzinga Pro . Last quarter, Netflix turned in mixed results . The company beat revenue estimates of $8.72 billion, turning in revenue of $8.83 billion, but missed earnings estimates of $2.21 per share when it reported earnings of $2.11 per share. The stock still moved higher as global paid memberships jumped 12.8% on ... Full story available on Benzinga.com - benzinga | 36m ago link | |
| TSLA US | Tesla Stock Is Trading Lower Again: What's Going On? Tesla Inc (NASDAQ: TSLA ) shares are trading lower Thursday, adding to losses of approximately 11% over the last week. Here’s a look at what’s going on . What Happened: Tesla stock is continuing a multi-day slide that has seen shares fall to their lowest levels in more than a year amid workforce cuts. Tesla kicked off the week facing selling pressure on reports the EV maker was planning to lay off more than 10% of its workforce. New reports indicate the company has also started cutting temporary staff. Tesla let go of 300 temporary workers in Germany on Thursday, according to Reuters. “These are not layoffs of Tesla workers,” a spokesperson for the company in Germany reportedly told Reuters. Reports from Tuesday afternoon also suggested that Tesla had pushed back the scheduled delivery dates for multiple Cybertruck buyers without providing a reason for ... Full story available on Benzinga.com - benzinga | 37m ago link | |
| DVN US | How Much Will Devon Energy Pay in Dividends This Year? The company's ultimate dividend level will be determined by the price of oil and management's capital allocation policy. - fool | 39m ago link | |
| ZYXI US | Zynex Sets First Quarter 2024 Earnings Call ENGLEWOOD, Colo., April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on... - prnewswire:443 | 44m ago link | |
| KLIC US | Kulicke & Soffa Schedules Second Quarter 2024 Conference Call for 8:00 AM EDT, May 2nd, 2024 SINGAPORE, April 18, 2024 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ('Kulicke & Soffa', 'K&S' or the 'Company'), a global leader in the design and manufacture of semiconductor, LED and electronic assembly equipment, today announced that a conference call is... - prnewswire:443 | 54m ago link | |
| MDT US | Medtronic Stock: Buy, Sell, or Hold? Can this struggling healthcare specialist turn things around? - fool | 54m ago link | |
| INFY US | Infosys Q4 Results: Profit zooms 30% YoY to Rs 7,969 cr; co pegs FY25 revenue growth at 1-3% - economictimes indiatimes | 54m ago link | |
| EFX US | Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were higher this morning, with the Dow futures gaining over 50 points on Thursday. Shares of Equifax Inc. (NYSE: EFX ) fell sharply in today’s pre-market trading after the company reported worse-than-expected first-quarter sales results and issued adjusted guidance below estimates . Equifax posted quarterly sales of $1.389 billion, missing market estimates of $1.400 billion, according to data from Benzinga Pro. Equifax shares dipped 9.5% to $215.00 in pre-market trading. Here are some big stocks recording losses in ... Full story available on Benzinga.com - benzinga | 55m ago link | |
| WTFC US | Wintrust Finl Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) Across the recent three months, 10 analysts have shared their insights on Wintrust Finl (NASDAQ: WTFC ), expressing a variety of opinions spanning from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 4 0 0 0 Last 30D 0 1 0 0 0 1M Ago 2 2 0 0 0 2M Ago 2 1 0 0 0 3M Ago 2 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $116.7, a high estimate of $135.00, and a low estimate of $110.00. This upward trend is evident, with the current average reflecting a 6.09% increase from the previous average price target of $110.00. Interpreting Analyst Ratings: A Closer Look The s - benzinga | 57m ago link | |
| IEX US | Unveiling 6 Analyst Insights On IDEX Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on IDEX (NYSE: IEX ) in the last three months. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 1 0 0 Last 30D 0 1 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Analysts have recently evaluated IDEX and provided 12-month price targets. The average target is $253.17, accompanied by a high estimate of $277.00 and a low estimate of $215.00. This current average reflects an increase of 8.94% from the previous average price target of $232.40. Analyzing Analyst Ratings: A Detailed Breakdown The perception of IDEX by financial experts is analyzed th - benzinga | 57m ago link | |
| GNUS US | Kartoon Studios Inc. Announces Pricing of up to $7 Million Registered Direct Offering of Common Stock BEVERLY HILLS, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Kartoon Studios Inc. (NYSE: TOON ) ('Kartoon Studios' or the 'Company'), a global end-to-end creator, producer, distributor, marketer, and licensor of entertainment brands, today announced the pricing of a registered direct offering of up to 7,000,000 shares of its common stock and/or pre-funded warrants to purchase shares of common stock (the 'Pre-funded Warrants') (the 'offering') to certain institutional investors at $1.00 per share of common stock and $0.99 per Pre-funded Warrant, for aggregate gross proceeds of up to approximately $7,000,000, prior to deducting placement agent fees and other offering expenses, pursuant to a securities purchase agreement (the 'SPA'). The first tranche of the offering consists of 4,000,000 shares of common stock and/or Pre-funded Warrants for aggregate gross proceeds to the Company of approximately $4,000,000, and is expected to close on or about Monday, April 22, 2024, subject to the - benzinga | 58m ago link | |
| MDB US | Decoding 26 Analyst Evaluations For MongoDB In the preceding three months, 26 analysts have released ratings for MongoDB (NASDAQ: MDB ), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 11 10 3 0 2 Last 30D 0 1 0 0 0 1M Ago 2 0 0 0 1 2M Ago 9 7 2 0 1 3M Ago 0 2 1 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $447.46, a high estimate of $550.00, and a low estimate of $272.00. This current average represents a 4.42% decrease from the previous average price target of $468.16. Diving into Analyst Ratings: An In-Depth Exploration The standing of MongoDB among financial experts be - benzinga | 58m ago link | |
| ENTG US | Looking Into Entegris's Recent Short Interest Entegris's (NYSE: ENTG ) short percent of float has fallen 3.12% since its last report. The company recently reported that it has 4.20 million shares sold short , which is 2.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.32 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga | 58m ago link | |
| CSL US | Expert Ratings For Carlisle Companies Carlisle Companies (NYSE: CSL ) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 4 0 0 0 Last 30D 0 1 0 0 0 1M Ago 2 3 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $424.5, a high estimate of $455.00, and a low estimate of $400.00. Witnessing a positive shift, the current average has risen by 11.71% from the previous average price target of $380.00. Interpreting Analyst Ratings: A Closer Look An in-depth analysis of recent analyst actions unveils how f - benzinga | 58m ago link | |
| CSX US | CSX solid and steady despite Baltimore bridge collapse, say analysts CSX Corp. is taking a sales hit of up to $30 million a month following the Baltimore bridge collapse, although analysts still see plenty of positives in the railroad operators first-quarter results, which it reported late Wednesday. - marketwatch | 59m ago link | |
| GNUS US | Kartoon Studios Inc. Announces Pricing of up to $7 Million Registered Direct Offering of Common Stock BEVERLY HILLS, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Kartoon Studios Inc. (NYSE American: TOON) (Kartoon Studios or the Company), a global end-to-end creator, producer, distributor, marketer, and licensor of entertainment brands, today announced the pricing of a registered direct offering of up to 7,000,000 shares of its common stock and/or pre-funded warrants to purchase shares of common stock (the Pre-funded Warrants) (the offering) to certain institutional investors at $1.00 per share of common stock and $0.99 per Pre-funded Warrant, for aggregate gross proceeds of up to approximately $7,000,000, prior to deducting placement agent fees and other offering expenses, pursuant to a securities purchase agreement (the SPA). - globenewswire | 59m ago link | |
| AJG US | Arthur J. Gallagher & Co. Acquires Fontenelle & Goodreau Insurance, LLC ROLLING MEADOWS, Ill., April 18, 2024 /PRNewswire/ -- Arthur J. Gallagher & Co. today announced the acquisition of Metairie, Louisiana-based Fontenelle & Goodreau Insurance, LLC. Terms of the transaction were not disclosed. Fontenelle & Goodreau Insurance offers commercial... - prnewswire:443 | 59m ago link | |
| PLBC US | PLUMAS BANCORP DECLARES QUARTERLY CASH DIVIDEND RENO, Nev., April 18, 2024 (GLOBE NEWSWIRE) -- Plumas Bancorp (Nasdaq:PLBC), the parent company of Plumas Bank (the Bank), today announced that the Board of Directors declared a regular quarterly cash dividend on Plumas Bancorp common stock of $0.27 per share, payable May 15, 2024, to stockholders of record as of May 1, 2024. - globenewswire | 59m ago link | |
| PEYE US | Precision Optics Announces Receipt of $720,000 Follow-On Production Order from Top Tier Defense/Aerospace Customer for New Optical Application GARDNER, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has received a $720,000 follow on production order from a top tier defense/aerospace company addressing a commercial application that leverages the Company's proprietary manufacturing technology developed for high precision micro-optics systems. - globenewswire | 59m ago link | |
| KR US | Beyond IV, the Fourth Generation of the Beyond Burger and Beyond Beef, Debuts at Grocery Stores Across the U.S. Including at Walmart and Kroger The new products are the companys meatiest, juiciest beef products yet, provide 21g of plant-based protein and are made with avocado oil, which offers heart-healthy monounsaturated fats, and helped lower the saturated fat to just 2g per serving - globenewswire | 59m ago link | |
| ONCT US | Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the first patient has been dosed in the fourth cohort of its Phase 1/2 study of ONCT-534 for the treatment of patients with advanced prostate cancer who are relapsed or refractory to approved androgen receptor pathway inhibitors (ARPI). Patients in the fourth dosing cohort will receive ONCT-534, the companys dual-action androgen receptor inhibitor (DAARI), at a dose of 300 mg taken orally each day. The decision to proceed to this higher dose level was made by the studys Safety Review Committee (SRC) after reviewing data from the patients treated to date, including the third dose level of 160 mg ONCT-534 daily. - globenewswire | 59m ago link | |
| VOLC US | Indonesia officials warn of potential tsunami amid volcano eruption A cloud of black ash reached nearly two miles into the air on Thursday, officials said, as several people were reportedly hit by gravel and rocks, requiring 'intensive treatment.' - cbsnews | 1h ago link | |
| TSM US | This is a fucking piece of shit TSM Today it will become 0 The first rule of investment: dont touch anything related to China submitted by /u/AwareSandwich3216 [link] [comments] - reddit | 1h ago link | |
| TSLA US | Tesla to lay off 14% of Buffalo, N.Y., workforce - marketwatch | 1h ago link | |
| JPM US | Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending' In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE: JPM ). In advance of the crisis, Jamie Dimon realized that 'underwriting standards were deteriorating across the industry,' with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, 'I really want you to watch out for subprime! We need to sell a lot of our positions. I’ve seen it before. This stuff could go up in smoke!” Don't Miss: Invest alongside execs from Uber, Facebook and Apple in this wellness app Transforming a $5.6 TRILLION dollar industry . Join the elite. Invest in ... Full story available on Benzinga.com - benzinga | 1h ago link | |
| INFY US | Infosys stock sinks toward longest losing streak in 2 years after revenue miss Infosyss stock continued its selloff Thursday toward a 10-month low, after the India-based information-technology consultant reported fiscal fourth-quarter revenue that missed expectations. - marketwatch | 1h ago link | |
| TSLA US | Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Morgan Stanley raised the price target for United Airlines Holdings, Inc. (NASDAQ: UAL ) from $75 to $80. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. United Airlines shares gained 17.5% to close at $48.74 on Wednesday. See how other analysts view this stock . Loop Capital slashed the price target for BJ's Wholesale Club Holdings, Inc. (NYSE: BJ ) from $85 to $80. Loop Capital analyst Laura Champine downgraded the stock from Buy to Hold. BJ's Wholesale Club shares fell 1.3% to close at $75.28 on Wednesday. See how other analysts view this stock . Wedbush increased Cinemark Holdings, Inc. (NYSE: CNK ) price target from $20 to $23. Wedbush analyst Michael Pachter maintained an Outperform rating. Cinemark shares closed at $18.13 on Wednesday. See how - benzinga | 1h ago link | |
| NEOG US | Neogen Forms Genomics Relationship with Performance Food Group LINCOLN, Neb., April 18, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has formed a genomics relationship with Performance Food Group (NYSE: PFGC), making the company the official genomics provider for the food group's PathProven service. With the support... - prnewswire:443 | 1h ago link | |
| APOG US | Apogee Enterprises Forecasts Topline Decline In FY25 Amid Strategic Actions: Details Apogee Enterprises Inc (NASDAQ: APOG ) reported fourth-quarter FY24 sales growth of 5.2% year-on-year to $361.84 million, beating the analyst consensus estimate of $337.83 million. Gross profit increased 13.3% to $88.5 million, and gross margin improved by 170 bps to 24.4%, primarily driven by higher pricing, improved product mix, and the impact of cost saving initiatives. The operating income for ... Full story available on Benzinga.com - benzinga | 1h ago link | |
| EVFM US | Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO -- Application allowed with broad method claims that are Orange Book-listable -- -- Once issued, this will be Evofem's fifth patent covering Hormone-Free 'In the Moment' Contraceptive Phexxi in the United States -- SAN DIEGO, April 18, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:... - prnewswire:443 | 1h ago link | |
| ABBV US | Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ) Showed Positive Results in Patients With Giant Cell Arteritis Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ; 15 mg) with a 26-week steroid taper regimen achieved sustained remission from week 12 through week 52 compared to 29 percent of patients... - prnewswire:443 | 1h ago link | |
| COST US | Mamas Creations Secures Costco Roadshow with Six Branded Items for Members in Northeast Region Costco Roadshow In-Store Sampling in May 2024 Provides Opportunity for New, National Placements with Costco - globenewswire | 1h ago link | |
| TSM US | Taiwan Semiconductor Manufacturing (TSM) Q1 2024 Earnings Call Transcript TSM earnings call for the period ending March 31, 2024. - fool | 1h ago link | |
| VRTX US | Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy? The biotech just added another potential growth driver to its pipeline. - fool | 1h ago link | |
| SNGX US | Soligenix Announces Pricing of $4.75 Million Public Offering PRINCETON, N.J., April 18, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ('Soligenix' or the 'Company'), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced the pricing... - prnewswire:443 | 1h ago link | |
| SPCB US | SuperCom Announces Pricing of $2.9 Million Registered Direct Offering TEL AVIV, Israel, April 18, 2024 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase... - prnewswire:443 | 1h ago link | |
| MGTA US | Adeia Enters into IP License Agreement with Magenta Telekom SAN JOSE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) ('Adeia' or the 'Company'), the company whose patented innovations shape the way the world explores and experiences entertainment, today announced Magenta Telekom, a leading provider of Internet, mobile communications, entertainment and business solutions, has entered into an agreement to license Adeias media intellectual property (IP) portfolio. - globenewswire | 1h ago link | |
| CHUY US | Chuy's Holdings, Inc. to Announce First Quarter 2024 Results on May 9, 2024 AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Chuy's Holdings, Inc. (NASDAQ: CHUY ) today announced that it will host a conference call to discuss first quarter 2024 financial results on Thursday, May 9, 2024 at 5:00 PM Eastern Time. A press release with first quarter 2024 financial results will be issued that same day after the market close. Hosting the call will be Steve Hislop, President and Chief Executive Officer, and Jon Howie, Vice President and ... Full story available on Benzinga.com - benzinga | 1h ago link | |
| MGPI US | MGP Ingredients Schedules First Quarter 2024 Conference Call/Webcast for Thursday, May 2 ATCHISON, Kan., April 18, 2024 (GLOBE NEWSWIRE) -- MGPIngredients, Inc. (NASDAQ: MGPI ), a leading provider of branded and distilled spirits, as well as food ingredient solutions, today announced that it will hold a conference call/webcast to discuss results for the first quarter ended March 31, 2024, on Thursday, May 2, at 10 a.m. ET. The company expects to release its financial results before the market opens that morning. Management on the call will include David Bratcher, CEO and President, and Brandon Gall, Vice President of Finance and CFO. The call/webcast will be available via: Webcast: ir.mgpingredients.com on the Events & Presentations page Conference Call: 844-308-6398 (domestic) or 412-717-9605 (international) Full story available on Benzinga.com - benzinga | 1h ago link | |
| TSLA US | 'I Think You Just Don't Like Elon,' Tesla Bull Tells Shortseller Even As She Admits Situation Right Now Is 'Murky' Tesla, Inc . (NASDAQ: TSLA ) shares are down 37.4% year-to-date, and traders are conflicted on their predictions for the EV giant’s future. This recent debate on TV between two analysts highlights the contrasting viewpoints. The Long Argument: Tesla shareholder and Managing Partner of Requisite Capital Management , Bryn Talkington acknowledged the stock’s current poor performance. She even admitted it could go lower, but emphasized a distinction between the stock price and the company itself. “What I wouldn’t discount is Elon because I think he is one of the most prolific innovators and engineers of our time,” Talkington said in a debate with Tesla short-seller Steve Weiss, Managing Partner of Short Hills Capital Partners, aired on Full story available on Benzinga.com - benzinga | 1h ago link | |
| HOMB US | All Operating Metrics Up and Expenses Down, Great Start at HOMB CONWAY, Ark., April 18, 2024 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NYSE: HOMB) (Home or the Company), parent company of Centennial Bank, released quarterly earnings today. - globenewswire | 1h ago link | |
| TSLA US | Tesla plan to re-run vote on Elon Musks record pay dealnow worth $45bnhas a fatal flaw, warns Tulane law professor By framing the June vote as a reward for past deeds, Tesla's board could end up making itself liable to a new legal challengethis time against corporate waste. - fortune | 1h ago link | |
| TSLA US | Elon Musk Backed Signal To Take On Mark Zuckerberg's WhatsApp, But Another Rival Says It's Spreading Like A 'Forest Fire': 'We're Sort Of A Threat' Tech billionaire Elon Musk has donated to and promoted secure messaging app Signal to take on Mark Zuckerberg's WhatsApp , but it's another rival that is closing the gap with the Meta Platforms Inc.-owned service. What Happened: Telegram Messenger creator Pavel Durov revealed that his messaging app has nearly a billion users and is spreading like a 'forest fire.' Speaking to conservative media personality Tucker Carlson , Durov revealed that Telegram is adding users at a breakneck speed of 2.5 million per day. 'Telegram is spreading like forest fire. Two and a half million users sign up every day, and we're sort of a threat.' See Also: Top Apple Exec Points To Steve Jobs Era For Lack Of Meeting Records, Expresses Uncertainty About App Store’s Profitability Durov brought this up when Carlson told him that he had heard ... Full story available on Benzinga.com - benzinga | 1h ago link | |
| SAGE US | In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics Sage Therapeutics (NASDAQ: SAGE ) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 6 1 0 Last 30D 1 0 0 0 0 1M Ago 0 1 2 1 0 2M Ago 0 0 2 0 0 3M Ago 0 0 2 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.67, with a high estimate of $29.00 and a low estimate of $14.00. Experiencing a 1.37% decline, the current average is now lower than the previous average price target of $24.00. Exploring Analyst Ratings: An In-Depth Overview A clear picture of Sage Therapeutics - benzinga | 1h ago link | |
| BECN US | Where Beacon Roofing Supply Stands With Analysts In the last three months, 4 analysts have published ratings on Beacon Roofing Supply (NASDAQ: BECN ), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 Analysts have set 12-month price targets for Beacon Roofing Supply, revealing an average target of $121.25, a high estimate of $135.00, and a low estimate of $115.00. Marking an increase of 19.66%, the current average surpasses the previous average price target of $101.33. Understanding Analyst Ratings: A Comprehensive Breakdown The analysis of recent analyst actio - benzinga | 1h ago link | |
| WINT US | Windtree Therapeutics Announces Reverse Stock Split WARRINGTON, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT) (Windtree or the Company), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today announced that the Companys Board of Directors has approved a 1-for-18 reverse stock split of its issued and outstanding common stock, par value of $0.001 per share (the Reverse Stock Split). The Reverse Stock Split will become effective at 11:59 p.m. Eastern Time on April 19, 2024 and the Companys common stock will open for trading on The Nasdaq Capital Market on a split-adjusted basis under the symbol WINT on April 22, 2024. At such time, the Companys common stock will also commence trading under a new CUSIP number, 97382D 501. - globenewswire | 1h ago link | |
| XYL US | Xylem Recognized for Excellence in Sustainable Finance WASHINGTON--(BUSINESS WIRE)-- #LetsSolveWater--Global water technology leader Xylem has been recognized for excellence in sustainable finance for its $1 billion Revolving Credit Facility. - feed businesswire | 1h ago link | |
| PEP US | Will PepsiCo Beat The Consensus In Q1? We expect the companys adjusted revenues to come in at $18.2 billion and earnings at $1.55 on a per share and adjusted basis. - forbes | 1h ago link |